Your browser doesn't support javascript.
loading
Reply: Insurance should cover vancomycin for primary sclerosing cholangitis.
Bowlus, Christopher L; Arrivé, Lionel; Bergquist, Annika; Deneau, Mark; Forman, Lisa; Ilyas, Sumera I; Lunsford, Keri E; Martinez, Mercedes; Sapisochin, Gonzalo; Shroff, Rachna; Tabibian, James H; Assis, David N.
Afiliação
  • Bowlus CL; Division of Gastroenterology and Hepatology, University of California Davis Health, Sacramento, California, USA.
  • Arrivé L; Hôpital Saint-Antoine, Paris, France.
  • Bergquist A; Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
  • Deneau M; Department of Pediatrics, University of Utah, Salt Lake City, Utah, USA.
  • Forman L; Division of Gastroenterology, University of Colorado, Aurora, Colorado, USA.
  • Ilyas SI; Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA.
  • Lunsford KE; New Jersey Medical School, Rutgers University, Newark, New Jersey, USA.
  • Martinez M; Vagelos College of Physician and Surgeons, Columbia University, New York, New York, USA.
  • Sapisochin G; Department of Surgery, University of Toronto, Toronto, Ontario, Canada.
  • Shroff R; Division of Hematology and Oncology Tucson, University of Arizona, Arizona, USA.
  • Tabibian JH; David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
  • Assis DN; Yale School of Medicine, New Haven, Connecticut, USA.
Hepatology ; 77(6): E176-E177, 2023 06 01.
Article em En | MEDLINE | ID: mdl-36695291

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Colangite Esclerosante / Seguro Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Colangite Esclerosante / Seguro Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article